These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 8317134)

  • 1. Acute renal failure following intravenous streptokinase infusion for acute myocardial infarction.
    Birnbaum Y; Strasberg B; Rechavia E; Neuman Y; Stahl B
    West J Med; 1993 Apr; 158(4):406-9. PubMed ID: 8317134
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum-sickness-like illness as a complication after streptokinase therapy for acute myocardial infarction.
    Schweitzer DH; van der Wall EE; Bosker HA; Scheffer E; Macfarlane JD
    Cardiology; 1991; 78(1):68-71. PubMed ID: 2021968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Serum sickness after fibrinolysis using intravenous streptokinase in myocardial infarction].
    Albert F; Dubourg O; Steg G; Delorme G; Bourdarias JP
    Arch Mal Coeur Vaiss; 1988 Aug; 81(8):1013-5. PubMed ID: 3144250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum sickness complicating intravenous streptokinase therapy in acute myocardial infarction.
    Alexopoulos D; Raine AE; Cobbe SM
    Eur Heart J; 1984 Dec; 5(12):1010-2. PubMed ID: 6534748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypersensitive reactions on readministration of streptokinase following acute myocardial infarction.
    Sahay RN; Kalantri SP; Gupta OP
    J Assoc Physicians India; 1994 Oct; 42(10):815. PubMed ID: 7876052
    [No Abstract]   [Full Text] [Related]  

  • 6. Lingual hematoma due to streptokinase in a patient with acute myocardial infarction.
    Kaya A; Ordu S; Albayrak ES; Aydin M; Erden I; Ozhan H
    Am J Emerg Med; 2010 Oct; 28(8):985.e1-2. PubMed ID: 20825845
    [No Abstract]   [Full Text] [Related]  

  • 7. The safety and efficacy of streptokinase in coronary reperfusion in patients with acute myocardial infarction.
    Hu D
    Chin Med J (Engl); 1995 Apr; 108(4):291-4. PubMed ID: 7789218
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cholesterol embolization after intravenous streptokinase therapy in acute myocardial infarction].
    Bucher A; Roald B
    Tidsskr Nor Laegeforen; 1993 Jun; 113(15):1844-5. PubMed ID: 8322322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Atheromatous material mobilization syndrome after thrombolytic therapy with streptokinase in acute myocardial infarct].
    Arpesani A; Beretta L; Giorgetti PL; Varesi C; Matturri L
    Minerva Cardioangiol; 1991 Jun; 39(6):251-4. PubMed ID: 1961445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombolytic failure with streptokinase in acute myocardial infarction using electrocardiogram criteria.
    Lee YY; Tee MH; Zurkurnai Y; Than W; Sapawi M; Suhairi I
    Singapore Med J; 2008 Apr; 49(4):304-10. PubMed ID: 18418522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Intracerebral hemorrhage and serum sickness after thrombolytic treatment in myocardial infarction].
    Kierkegaard A
    Lakartidningen; 1991 Sep; 88(38):3069-70. PubMed ID: 1921594
    [No Abstract]   [Full Text] [Related]  

  • 12. [Thrombolytic therapy in acute myocardial infarct and pulmonary artery thromboembolism].
    Iakovlev VB; Gospodarenko AL; Makarenko AS
    Voen Med Zh; 1993 Jun; (6):45-7. PubMed ID: 8367952
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute anuric renal failure with streptokinase therapy in a patient with acute venous thromboembolic disease and the review of renal side effects of streptokinase.
    Onen Z; Akkoca Yildiz O; Eriş Gülbay B; Karabiyikoğlu G
    Tuberk Toraks; 2008; 56(4):456-61. PubMed ID: 19123085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Complications of thrombolytic treatment of acute myocardial infarction].
    Ugeskr Laeger; 1990 Aug; 152(33):2370-2. PubMed ID: 2219479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe backache during thrombolytic therapy with streptokinase.
    Suresh V; Maliyil MV
    J Assoc Physicians India; 1996 Oct; 44(10):743. PubMed ID: 9251356
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum sickness and acute renal failure after streptokinase therapy for myocardial infarction.
    Davies KA; Mathieson P; Winearls CG; Rees AJ; Walport MJ
    Clin Exp Immunol; 1990 Apr; 80(1):83-8. PubMed ID: 2323103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accelerated streptokinase--a new thrombolytic regimen in acute myocardial infarction.
    Tatu-Chiţoiu G; Teodorescu C; Flueraşu A; Căpraru P; Guran M; Dan M; Chioncel V; Bumbu A; Cornaciu S
    Rom J Intern Med; 1998; 36(3-4):183-96. PubMed ID: 10822515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rhabdomyolysis and multiple system organ failure with streptokinase.
    Montgomery HE; McIntyre CW; Almond MK; Davies K; Pumphrey CW; Bennett D
    BMJ; 1995 Dec; 311(7018):1472. PubMed ID: 8520338
    [No Abstract]   [Full Text] [Related]  

  • 19. [The characteristics of thrombolytic therapy in myocardial infarct in middle-aged and elderly patients].
    Teslia AN; Kolesnikov SA; Mikhaĭlov AA
    Voen Med Zh; 1999 Jul; 320(7):40-4. PubMed ID: 10484919
    [No Abstract]   [Full Text] [Related]  

  • 20. The need to identify patients who have received streptokinase therapy.
    Salem DN; Pauker SG
    N Engl J Med; 1991 Jun; 324(24):1742. PubMed ID: 2034254
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.